Catalyst Bio (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBIO | AMGN | BMY | VRTX | GILD |
| Company | Catalyst Bio | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 8.4990 | 281.10 | 58.61 | 448.46 | 88.11 |
| High | 8.6940 | 284.81 | 58.83 | 451.76 | 89.08 |
| Low | 7.2000 | 278.56 | 57.67 | 445.38 | 87.77 |
| Last | 7.6695 | 284.46 | 57.90 | 448.84 | 88.80 |
| Change | -0.2085 | +4.51 | -0.33 | +0.83 | +1.05 |
| % Change | -2.65% | +1.61% | -0.57% | +0.19% | +1.20% |
| Volume | 32,246 | 2,008,343 | 3,364,758 | 736,847 | 1,527,549 |
| 20-Day Average Volume | 378,990 | 2,669,260 | 11,971,254 | 1,256,598 | 7,515,003 |
| Previous Close | 7.8780 | 279.95 | 58.23 | 448.01 | 87.75 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.4494 | 308.53 | 55.65 | 480.22 | 90.85 |
| 20-Day Raw Stochastic | 71.38% | 16.66% | 64.13% | 5.43% | 21.65% |
| 20-Day Relative Strength | 54.01% | 31.94% | 59.52% | 40.44% | 51.54% |
| Weighted Alpha | +18.13 | -0.77 | +24.64 | +17.71 | +24.32 |
| Today's Opinion | 88% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 88% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 88% Buy | 8% Buy | 88% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.72% since 10/23/23 | -5.67% since 11/13/24 | -1.12% since 11/13/24 | -9.13% since 11/13/24 | -4.08% since 11/13/24 |
| Low | 0.3720 on 10/24/23 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.38 on 11/20/24 | 86.08 on 11/19/24 |
| High | 0.5800 on 10/27/23 | 298.48 on 11/14/24 | 59.73 on 11/14/24 | 496.33 on 11/14/24 | 92.66 on 11/14/24 |
| 1-Month | |||||
| %Chg | +6.01% since 09/29/23 | -11.60% since 10/18/24 | +8.52% since 10/18/24 | -6.95% since 10/18/24 | +2.46% since 10/18/24 |
| Low | 0.3200 on 10/13/23 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.38 on 11/20/24 | 85.60 on 10/22/24 |
| High | 0.5880 on 10/20/23 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +36.38% since 07/28/23 | -13.46% since 08/20/24 | +17.92% since 08/20/24 | -7.78% since 08/20/24 | +18.87% since 08/20/24 |
| Low | 0.3200 on 10/13/23 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.38 on 11/20/24 | 74.80 on 08/21/24 |
| High | 0.7400 on 08/23/23 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +141.18% since 04/28/23 | -9.60% since 05/20/24 | +33.20% since 05/20/24 | +0.80% since 05/20/24 | +30.86% since 05/20/24 |
| Low | 0.2000 on 05/01/23 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 0.7400 on 08/23/23 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 19,418 | 150,482,384 | 118,100,752 | 115,375,568 | 109,359,840 |
| Shares Outstanding, K | 37,978 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 790,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -8,240,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -1,580,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.05 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.04 on 10/26/23 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/13/23 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | 0.569 on 08/20/15 | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | 08/20/15 | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.50 | 48.55 | 0.00 | 19.97 |